255 related articles for article (PubMed ID: 15013693)
1. The uses of carcinogen-DNA adduct measurement in establishing mechanisms of mutagenesis and in chemoprevention.
Baird WM; Mahadevan B
Mutat Res; 2004 Mar; 547(1-2):1-4. PubMed ID: 15013693
[TBL] [Abstract][Full Text] [Related]
2. Environmental and chemical carcinogenesis.
Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
[TBL] [Abstract][Full Text] [Related]
3. Biological relevance of adduct detection to the chemoprevention of cancer.
Sharma RA; Farmer PB
Clin Cancer Res; 2004 Aug; 10(15):4901-12. PubMed ID: 15297390
[TBL] [Abstract][Full Text] [Related]
4. Carcinogen-DNA and carcinogen-protein adducts in molecular epidemiology.
Wild CP; Pisani P
IARC Sci Publ; 1997; (142):143-58. PubMed ID: 9354917
[TBL] [Abstract][Full Text] [Related]
5. Carcinogen-DNA and protein adducts: biomarkers for cohort selection and modifiable endpoints in chemoprevention trials.
Kensler TW; Groopman JD
J Cell Biochem Suppl; 1996; 25():85-91. PubMed ID: 9027603
[TBL] [Abstract][Full Text] [Related]
6. Adducts to nuclear DNA and mitochondrial DNA as biomarkers in chemoprevention.
De Flora S; Balansky R; Scatolini L; Di Marco C; Gasparini L; Orlando M; Izzotti A
IARC Sci Publ; 1996; (139):291-301. PubMed ID: 8923039
[TBL] [Abstract][Full Text] [Related]
7. Carcinogen-DNA adducts as a biomarker for cancer risk.
Rundle A
Mutat Res; 2006 Aug; 600(1-2):23-36. PubMed ID: 16824556
[TBL] [Abstract][Full Text] [Related]
8. Dna adducts, mutations, and cancer 2000.
Hemminki K; Koskinen M; Rajaniemi H; Zhao C
Regul Toxicol Pharmacol; 2000 Dec; 32(3):264-75. PubMed ID: 11162720
[TBL] [Abstract][Full Text] [Related]
9. Use of carcinogen-DNA and carcinogen-protein adduct biomarkers for cohort selection and as modifiable end points in chemoprevention trials.
Kensler TW; Groopman JD; Wogan GN
IARC Sci Publ; 1996; (139):237-48. PubMed ID: 8923034
[TBL] [Abstract][Full Text] [Related]
10. [The role of testing DNA adducts and proteins in monitoring cancer risk].
Lutz W; Barański B
Med Pr; 1991; 42(1):67-75. PubMed ID: 1921717
[TBL] [Abstract][Full Text] [Related]
11. Differential removal of DNA adducts derived from anti-diol epoxides of dibenzo[a,l]pyrene and benzo[a]pyrene in human cells.
Dreij K; Seidel A; Jernström B
Chem Res Toxicol; 2005 Apr; 18(4):655-64. PubMed ID: 15833025
[TBL] [Abstract][Full Text] [Related]
12. DNA adducts as markers of exposure and risk.
Phillips DH
Mutat Res; 2005 Sep; 577(1-2):284-92. PubMed ID: 15922369
[TBL] [Abstract][Full Text] [Related]
13. Selection and validation of biomarkers for chemoprevention: the contribution of epidemiology.
Vineis P; Veglia F
IARC Sci Publ; 2001; 154():57-68. PubMed ID: 11220669
[TBL] [Abstract][Full Text] [Related]
14. Embryonic turkey liver: activities of biotransformation enzymes and activation of DNA-reactive carcinogens.
Perrone CE; Ahr HJ; Duan JD; Jeffrey AM; Schmidt U; Williams GM; Enzmann HH
Arch Toxicol; 2004 Oct; 78(10):589-98. PubMed ID: 15167984
[TBL] [Abstract][Full Text] [Related]
15. Exposure biomarkers for the study of toxicological impact on carcinogenic processes.
Farmer PB
IARC Sci Publ; 2004; (157):71-90. PubMed ID: 15055291
[TBL] [Abstract][Full Text] [Related]
16. Immunological methods for detection of carcinogen-DNA damage in humans.
Santella RM
Cancer Epidemiol Biomarkers Prev; 1999 Sep; 8(9):733-9. PubMed ID: 10498391
[TBL] [Abstract][Full Text] [Related]
17. Methods for testing compounds for DNA adduct formation.
Reddy MV
Regul Toxicol Pharmacol; 2000 Dec; 32(3):256-63. PubMed ID: 11162719
[TBL] [Abstract][Full Text] [Related]
18. Creating context for the use of DNA adduct data in cancer risk assessment: I. Data organization.
Jarabek AM; Pottenger LH; Andrews LS; Casciano D; Embry MR; Kim JH; Preston RJ; Reddy MV; Schoeny R; Shuker D; Skare J; Swenberg J; Williams GM; Zeiger E
Crit Rev Toxicol; 2009; 39(8):659-78. PubMed ID: 19743944
[TBL] [Abstract][Full Text] [Related]
19. Haemoglobin adducts of N-nitroso compounds.
Richter E
Eur J Cancer Prev; 1996 Sep; 5 Suppl 1():115-9. PubMed ID: 8972305
[No Abstract] [Full Text] [Related]
20. Risk assessment of DNA-reactive carcinogens in food.
Jeffrey AM; Williams GM
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):628-35. PubMed ID: 15990138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
